UnitedHealth Group Incorporated (NYSE:UNH) is Cambridge Financial Group Inc.’s Largest Position

Cambridge Financial Group Inc. lessened its stake in UnitedHealth Group Incorporated (NYSE:UNHGet Rating) by 12.5% in the 1st quarter, according to its most recent filing with the SEC. The firm owned 18,331 shares of the healthcare conglomerate’s stock after selling 2,608 shares during the quarter. UnitedHealth Group accounts for approximately 4.2% of Cambridge Financial Group Inc.’s portfolio, making the stock its biggest position. Cambridge Financial Group Inc.’s holdings in UnitedHealth Group were worth $9,348,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also made changes to their positions in the stock. Everett Harris & Co. CA raised its position in shares of UnitedHealth Group by 9.7% during the 4th quarter. Everett Harris & Co. CA now owns 1,697 shares of the healthcare conglomerate’s stock worth $852,000 after acquiring an additional 150 shares in the last quarter. Valmark Advisers Inc. increased its position in UnitedHealth Group by 1.5% during the fourth quarter. Valmark Advisers Inc. now owns 4,335 shares of the healthcare conglomerate’s stock worth $2,177,000 after buying an additional 65 shares during the period. Stonebridge Financial Planning Group LLC increased its position in UnitedHealth Group by 28.7% during the fourth quarter. Stonebridge Financial Planning Group LLC now owns 987 shares of the healthcare conglomerate’s stock worth $460,000 after buying an additional 220 shares during the period. HC Advisors LLC acquired a new position in UnitedHealth Group during the fourth quarter worth approximately $225,000. Finally, Clarius Group LLC increased its holdings in shares of UnitedHealth Group by 0.8% in the fourth quarter. Clarius Group LLC now owns 10,270 shares of the healthcare conglomerate’s stock valued at $5,157,000 after purchasing an additional 82 shares during the period. Hedge funds and other institutional investors own 87.48% of the company’s stock.

Insider Activity at UnitedHealth Group

In related news, Director Richard T. Burke sold 2,500 shares of the stock in a transaction dated Monday, May 16th. The stock was sold at an average price of $493.25, for a total value of $1,233,125.00. Following the completion of the transaction, the director now owns 1,220,000 shares of the company’s stock, valued at $601,765,000. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. In other UnitedHealth Group news, Director Richard T. Burke sold 2,500 shares of the stock in a transaction that occurred on Monday, May 16th. The stock was sold at an average price of $493.25, for a total transaction of $1,233,125.00. Following the transaction, the director now owns 1,220,000 shares of the company’s stock, valued at approximately $601,765,000. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, CFO John F. Rex sold 13,183 shares of the stock in a transaction that occurred on Friday, July 29th. The stock was sold at an average price of $541.53, for a total value of $7,138,989.99. Following the transaction, the chief financial officer now directly owns 141,508 shares in the company, valued at approximately $76,630,827.24. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 130,144 shares of company stock valued at $69,269,555. Insiders own 0.40% of the company’s stock.

UnitedHealth Group Trading Up 0.2 %

NYSE:UNH traded up $1.31 on Friday, hitting $535.06. 2,373,351 shares of the stock were exchanged, compared to its average volume of 2,833,444. The stock has a market cap of $500.48 billion, a PE ratio of 27.94, a PEG ratio of 1.65 and a beta of 0.76. The company has a current ratio of 0.77, a quick ratio of 0.78 and a debt-to-equity ratio of 0.60. The stock has a fifty day moving average of $506.46 and a 200-day moving average of $499.44. UnitedHealth Group Incorporated has a fifty-two week low of $383.12 and a fifty-two week high of $553.29.

UnitedHealth Group (NYSE:UNHGet Rating) last issued its earnings results on Friday, July 15th. The healthcare conglomerate reported $5.57 earnings per share for the quarter, topping the consensus estimate of $5.24 by $0.33. UnitedHealth Group had a return on equity of 25.45% and a net margin of 5.95%. The company had revenue of $80.33 billion during the quarter, compared to the consensus estimate of $79.68 billion. During the same quarter in the prior year, the business earned $4.70 earnings per share. The company’s revenue was up 12.6% compared to the same quarter last year. As a group, equities analysts expect that UnitedHealth Group Incorporated will post 21.86 earnings per share for the current fiscal year.

UnitedHealth Group Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, June 28th. Investors of record on Monday, June 20th were issued a $1.65 dividend. The ex-dividend date was Thursday, June 16th. This represents a $6.60 dividend on an annualized basis and a yield of 1.23%. This is an increase from UnitedHealth Group’s previous quarterly dividend of $1.45. UnitedHealth Group’s dividend payout ratio is currently 34.46%.

Analyst Upgrades and Downgrades

A number of research firms have recently issued reports on UNH. Cowen boosted their target price on UnitedHealth Group from $512.00 to $596.00 in a report on Monday, April 18th. BMO Capital Markets lifted their price target on UnitedHealth Group from $600.00 to $610.00 in a research note on Wednesday, July 20th. Credit Suisse Group lifted their price target on UnitedHealth Group from $575.00 to $579.00 and gave the company an “outperform” rating in a research note on Monday, July 18th. Raymond James boosted their target price on UnitedHealth Group from $540.00 to $620.00 and gave the stock a “strong-buy” rating in a research report on Tuesday, April 19th. Finally, Loop Capital initiated coverage on UnitedHealth Group in a research report on Thursday, June 16th. They set a “buy” rating and a $575.00 target price on the stock. Three analysts have rated the stock with a hold rating, sixteen have issued a buy rating and two have issued a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $582.50.

UnitedHealth Group Company Profile

(Get Rating)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage and well-being services to individuals age 50 and older addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children's health insurance and health care programs; health and dental benefits; and hospital and clinical services.

Featured Articles

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNHGet Rating).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.